KIDS

OrthoPediatrics Corp.

61
Fundamentals73/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential25/ 100

KIDS's outlook is improving, though it still trails on the overall score.

LLY

Eli Lilly and Company

78
Fundamentals85/ 100
Valuation62/ 100
Upside potential72/ 100
Risk potential15/ 100

LLY has the edge over KIDS overall, supported by stronger modeled upside and stronger valuation.

KIDS Fundamentals

MetricStatus
Healthy
Under pressure
Stable
Unavailable

KIDS's revenue is currently healthy, and its cash flow is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.

LLY Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.

KIDS PE Valuation

KIDS has no meaningful PE right now: it lost money over the past year.

LLY PE Valuation

CHEAPFAIREXPENSIVE37x74x111x147x
CHEAPFAIREXPENSIVE37x74x111x147x
LevelPEPriceVs current
Cheap27x$845-41%
Forward30x$1,427—
Current46x$1,427—
Fair48x$1,466+2.7%
Expensive85x$2,612+83%

Historical ranges are pointers, not guarantees.

LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.

KIDS Forward outlook

MetricOutlook
--
Losses shrinking
Growth
Strongly improving
Limited
High

Analysts expect KIDS's losses to shrink, with revenue growing.

LLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

Analysts expect strong earnings and revenue growth for LLY, with profitability improving.

KIDS Risk to reward

ScenarioChangePrice
Upside+35%$43.94
Downside-25%$24.30

Calculated from the latest close: $32.58 on Nov 12.

KIDS trails LLY on modeled risk to reward, with less potential upside and more potential downside.

LLY Risk to reward

ScenarioChangePrice
Upside+39%$1,988.49
Downside-15%$1,209.08

Calculated from the latest close: $1,427.28 on Nov 12.

LLY has a better modeled risk to reward balance than KIDS, with more potential upside and less potential downside.

KIDS Earnings Per Share

Q4 2023: $-0.92Q1 2024: $-0.96Q2 2024: $-1.09Q3 2024: $-1.23Q4 2024: $-1.64Q1 2025: $-1.76Q2 2025: $-1.80Q3 2025: $-1.96Q4 2025: $-1.69Q1 2026: $-1.68Q2 2026: $-1.68Q3 2026: $-1.43
Q4 2023: $-0.92Q1 2024: $-0.96Q2 2024: $-1.09Q3 2024: $-1.23Q4 2024: $-1.64Q1 2025: $-1.76Q2 2025: $-1.80Q3 2025: $-1.96Q4 2025: $-1.69Q1 2026: $-1.68Q2 2026: $-1.68Q3 2026: $-1.43
QuarterTTM EPSYoY
Q3 2026-$1.43+$0.53
Q2 2026-$1.68+$0.12
Q1 2026-$1.68+$0.08
Q4 2025-$1.69-$0.05
Q3 2025-$1.96-$0.73
Q2 2025-$1.80-$0.71
Q1 2025-$1.76-$0.80
Q4 2024-$1.64-$0.72

KIDS is still losing money, but less than at its worst: $1.43 per share over the past year, against $2.05 at its worst in early 2021.

LLY Earnings Per Share

Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
QuarterTTM EPSYoY
Forward$46.82+52%
Q3 2026$30.81+51%
Q2 2026$29.80+95%
Q1 2026$28.15+129%
Q4 2025$22.95+96%
Q3 2025$20.44+121%
Q2 2025$15.30+88%
Q1 2025$12.29+81%
Q4 2024$11.71+102%

LLY has the edge over KIDS on earnings quality, reporting a profit while its opponent remains loss making.

KIDS Quarterly Revenue

Q4 2023: $38MQ1 2024: $45MQ2 2024: $53MQ3 2024: $55MQ4 2024: $53MQ1 2025: $52MQ2 2025: $61MQ3 2025: $61MQ4 2025: $62MQ1 2026: $59MQ2 2026: $71MQ3 2026: $73M
Q4 2023: $38MQ1 2024: $45MQ2 2024: $53MQ3 2024: $55MQ4 2024: $53MQ1 2025: $52MQ2 2025: $61MQ3 2025: $61MQ4 2025: $62MQ1 2026: $59MQ2 2026: $71MQ3 2026: $73M
QuarterRevenueYoY
Q3 2026$72.7M+19%
Q2 2026$70.5M+15%
Q1 2026$59.4M+13%
Q4 2025$61.6M+17%
Q3 2025$61.3M+12%
Q2 2025$61.1M+16%
Q1 2025$52.4M+17%
Q4 2024$52.7M+40%

KIDS's revenue has grown year over year for 23 quarters in a row: $73M last quarter, up 19% from the same quarter a year ago.

LLY Quarterly Revenue

Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
QuarterRevenueYoY
Q3 2026$24.4B+39%
Q2 2026$23B+48%
Q1 2026$19.8B+56%
Q4 2025$19.3B+43%
Q3 2025$17.6B+54%
Q2 2025$15.6B+38%
Q1 2025$12.7B+45%
Q4 2024$13.5B+45%

LLY has the edge over KIDS on sales, with stronger typical year-over-year growth.

KIDS Free Cash Flow

Q4 2023: −$11MQ1 2024: −$13MQ2 2024: −$13MQ3 2024: −$12MQ4 2024: −$4MQ1 2025: −$8MQ2 2025: −$14MQ3 2025: −$3MQ4 2025: $10MQ1 2026: −$5MQ2 2026: −$3MQ3 2026: $2M
Q4 2023: −$11MQ1 2024: −$13MQ2 2024: −$13MQ3 2024: −$12MQ4 2024: −$4MQ1 2025: −$8MQ2 2025: −$14MQ3 2025: −$3MQ4 2025: $10MQ1 2026: −$5MQ2 2026: −$3MQ3 2026: $2M
QuarterFree cash flowYoY
Q3 2026$1.6M+$5M
Q2 2026-$3.1M+$10.8M
Q1 2026-$5M+$3.3M
Q4 2025$9.7M+$13.5M
Q3 2025-$3.4M+$8.2M
Q2 2025-$13.9M-$1.1M
Q1 2025-$8.4M+$4.8M
Q4 2024-$3.7M+$7.7M

KIDS has the edge over LLY on cash flow, with more consistent year-over-year improvement.

LLY Free Cash Flow

Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
QuarterFree cash flowYoY
Q3 2026$8.2B+22%
Q2 2026$7.8B+458%
Q1 2026$3B+1826%
Q4 2025$677.9M-31%
Q3 2025$6.7B+186%
Q2 2025$1.4B+476%
Q1 2025$156.1M-13%
Q4 2024$977.8M+$2.4B

LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.

KIDS Total Shares

Q4 2023: 23MQ1 2024: 23MQ2 2024: 23MQ3 2024: 23MQ4 2024: 23MQ1 2025: 23MQ2 2025: 23MQ3 2025: 24MQ4 2025: 23MQ1 2026: 24MQ2 2026: 24MQ3 2026: 24M
Q4 2023: 23MQ1 2024: 23MQ2 2024: 23MQ3 2024: 23MQ4 2024: 23MQ1 2025: 23MQ2 2025: 23MQ3 2025: 24MQ4 2025: 23MQ1 2026: 24MQ2 2026: 24MQ3 2026: 24M
PeriodChange %Net change
Quarterly+0.4%+105K shares
1 year+2.5%+588K shares
3 years+6.1%+1.4M shares
5 years+25%+4.9M shares
Available history+65%+9.5M shares

KIDS has 24M diluted shares, up 2.5% from a year ago.

LLY Total Shares

Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
PeriodChange %Net change
Quarterly0%-300K shares
1 year-0.6%-5.4M shares
3 years-0.7%-6.4M shares
5 years-1.9%-17.4M shares
Available history-4.5%-42.3M shares

LLY has the edge over KIDS on shareholder dilution, with a more favorable share count trend.

KIDS Net Leverage

KIDS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LLY Net Leverage

Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
QuarterNet LeverageStatus
Q3 20261.2xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.3xHealthy
Q3 20251.3xHealthy
Q2 20252.0xHealthy
Q1 20252.3xModerate
Q4 20242.1xModerate

LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.

KIDS Weekly Momentum

MetricValueStatus
RSI78.2Overbought
Stochastic84.8Overbought

KIDS's weekly RSI is 78 (overbought) and its Stochastic is 85 (overbought).

LLY Weekly Momentum

MetricValueStatus
RSI68.3Neutral
Stochastic84.1Overbought

LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).

KIDS PE vs Healthcare Sector

MetricKIDSSector medianRelative
PEN/A26x—

KIDS has no meaningful PE right now: it lost money over the past year.

LLY PE vs Healthcare Sector

MetricLLYSector medianRelative
PE46x26x79% above
PE %482919 pts above

LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.

KIDS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$26.025% above
20 week MA$23.539% above
50 week MA$19.964% above
100 week MA$20.658% above
200 week MA$27.319% above

KIDS has climbed back above all five of its weekly moving averages, and it's now 19% above its 200-week average.

LLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,279.412% above
20 week MA$1,218.817% above
50 week MA$1,102.229% above
100 week MA$954.150% above
200 week MA$797.579% above

LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.

KIDS Yearly ROI

YearStart priceEnd priceROI
2020$46.5$46.3-0.4%
2021$46.3$60.8+31%
2022$60.8$38.0-37%
2023$38.0$32.5-14%
2024$32.5$22.9-30%
2025$22.9$17.3-24%
2026 YTD$17.3$32.6+88%

KIDS has the edge over LLY on returns for 2026, with the stronger performance.

LLY Yearly ROI

YearStart priceEnd priceROI
2020$131.5$166.7+27%
2021$166.7$273.1+64%
2022$273.1$367.9+35%
2023$367.9$582.9+58%
2024$582.9$783.2+34%
2025$783.2$1,077.8+38%
2026 YTD$1,077.8$1,427.3+32%

LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.

Give your agent the market.

Get API key